Kestra Medical (KMTS) counsel earns 58,832-share stock award

Rhea-AI Filing Summary

Kestra Medical Technologies, Ltd. reported that director and General Counsel Traci S. Umberger acquired 58,832 Common Shares on July 15, 2026 at $0.00 per share, reflecting the vesting of performance-based RSUs (PSUs) granted on July 17, 2025. After this award, Umberger directly holds 221,634 Common Shares.

Insider Trade Summary

Net Buyer: 58,832 shares

Net Buy 1 txn

Insider Umberger Traci S

Role See Remarks

Type	Security	Shares	Price	Value
Grant/Award	Common Shares F1	58,832	$0.00	$0.00

Holdings After Transaction: Common Shares — 221,634 shares (Direct)

Footnotes (1)

1. F1. Represents common shares earned with respect to an award of performance-based RSUs ("PSUs") granted on July 17, 2025, as determined based on the Issuer's achievement of specified performance goals. 100% of the PSUs vested on July 15, 2026.

Key Figures

Common Shares acquired: 58,832 shares Price per share: $0.00 Total direct holdings after transaction: 221,634 shares +2 more

5 metrics

Common Shares acquired 58,832 shares Grant, award, or other acquisition on July 15, 2026

Price per share $0.00 Award price for Common Shares received upon PSU vesting

Total direct holdings after transaction 221,634 shares Common Shares directly owned by Traci S. Umberger after July 15, 2026

PSU grant date July 17, 2025 Performance-based RSUs that earned these shares were granted on this date

PSU vesting date July 15, 2026 100% of PSUs vested and delivered Common Shares on this date

Key Terms

performance-based RSUs, PSUs, vested

3 terms

performance-based RSUs financial

"Represents common shares earned with respect to an award of performance-based RSUs"

Performance-based restricted stock units (RSUs) are promises to deliver company shares to employees only if the business meets specific goals, such as revenue, profit, stock-price targets, or strategic milestones. For investors, they matter because they change future share supply and align management incentives with company results—like a salesperson whose bonus only pays out when sales targets are hit—so they can affect earnings, dilution, and confidence in leadership.

PSUs financial

"An award of performance-based RSUs (PSUs) granted on July 17, 2025"

PSUs are company shares promised to employees or executives that only become actual stock if the business hits specific performance targets over a set period. For investors, PSUs matter because they link pay to measurable outcomes — similar to a conditional bonus that converts into ownership — which can influence management decisions, dilution of shares, and signals about confidence in future results.

vested financial

"100% of the PSUs vested on July 15, 2026"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/17/2026 - 05:50 PM Accepted by SEC EDGAR 07/17/2026 - 05:49 PM Learn about SEC filing dates

FAQ

What insider transaction did KMTS report for Traci S. Umberger?

Traci S. Umberger acquired 58,832 Common Shares of Kestra Medical on July 15, 2026 at $0.00 per share. The shares were delivered upon vesting of performance-based RSUs, categorized as a grant, award, or other acquisition rather than an open-market purchase.

How many KMTS shares does Traci S. Umberger own after this award?

Following the July 15, 2026 transaction, Traci S. Umberger directly holds 221,634 Common Shares of Kestra Medical. This total reflects her updated direct ownership after 58,832 performance-based RSUs vested and converted into Common Shares on that date.

What is the nature of the 58,832 KMTS shares acquired on July 15, 2026?

The 58,832 Common Shares represent stock earned from an award of performance-based RSUs (PSUs). These PSUs were tied to Kestra Medical’s achievement of specified performance goals, with 100% of the PSUs vesting on July 15, 2026 and delivering the shares at no cash cost.

When were the KMTS performance-based RSUs granted and when did they vest?

The performance-based RSUs (PSUs) that produced the 58,832 shares were granted on July 17, 2025. According to the disclosure, 100% of these PSUs vested on July 15, 2026, at which point the earned Common Shares were delivered to Traci S. Umberger.

Was the reported KMTS insider transaction under a Rule 10b5-1 plan?

No. The filing’s Rule 10b5-1 checkbox is not marked as affirmative, indicating the transaction was not reported as made under a Rule 10b5-1 trading plan. The acquisition instead reflects vesting of performance-based RSUs awarded as compensation.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Umberger Traci S

(Last) (First) (Middle)

3933 LAKE WASHINGTON BLVD NE, SUITE 200

(Street)

KIRKLAND WASHINGTON 98033

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KESTRA MEDICAL TECHNOLOGIES, LTD. [ KMTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	07/15/2026		A		58,832(1)	A	$0	221,634	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents common shares earned with respect to an award of performance-based RSUs ("PSUs") granted on July 17, 2025, as determined based on the Issuer's achievement of specified performance goals. 100% of the PSUs vested on July 15, 2026.

Remarks:

General Counsel and Chief Adminstrative Officer

	/s/ Traci S. Umberger	07/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)